HCPCS Level II drug code
J9073 — Injection, cyclophosphamide (dr. reddy's), 5 mg
In short
J9073 is the HCPCS Level II code for injection, cyclophosphamide (dr. reddy's), 5 mg. CMS assigns NDCs for Cyclophosphamide and Cyclophosphamide (Ingenus) to it. One billing unit is 5 mg. The Medicare Part B payment limit is $0.465 per unit (October 1, 2026 through December 31, 2026).
Code
CMS HCPCS file- Descriptor
- Injection, cyclophosphamide (dr. reddy's), 5 mg
- Short descriptor
- Inj cyclophos dr reddys 5 mg
- Code set
- HCPCS Level II, maintained by CMS
- Effective
- Apr 1, 2025
The billing unit is read from the descriptor. Confirm it against the CMS file before billing.
Medicare Part B payment limit
CMS ASP fileEffective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files
Units and claim line
Units = dose given ÷ 5 mg. For example, 500 mg is 100 units. Enter the dose to get the units and the NDC line for the CMS-1500 and the 837P.
Enter the dose given to build the claim line.
NDCs billed under J9073
CMS’s ASP NDC–HCPCS crosswalk (effective October 1, 2026 through December 31, 2026) assigns 9 NDCs to J9073 for Cyclophosphamide and Cyclophosphamide (Ingenus). Billing units per package are CMS’s figures for this code’s unit.
| Drug | NDC (11-digit) | Labeler | Package | Billing units per package |
|---|---|---|---|---|
| Cyclophosphamide | 68001-0564-22 | BluePoint Laboratories | 5 | 200 |
| Cyclophosphamide | 68001-0565-28 | BluePoint Laboratories | 10 | 400 |
| Cyclophosphamide | 70860-0218-10 | Athenex Pharmaceutical Division, LLC | 10 | 400 |
| Cyclophosphamide | 75907-0189-35 | Dr. Reddy's Laboratories Inc. | 10 | 400 |
| Cyclophosphamide | 75907-0190-07 | Dr. Reddy's Laboratories Inc. | 5 | 200 |
| Cyclophosphamide | 75907-0191-02 | Dr. Reddy's Laboratories Inc. | 2.5 | 100 |
| Cyclophosphamide (Ingenus) | 50742-0519-02 | Ingenus Pharmaceuticals LLC | 2.5 | 100 |
| Cyclophosphamide (Ingenus) | 50742-0520-05 | Ingenus Pharmaceuticals LLC | 5 | 200 |
| Cyclophosphamide (Ingenus) | 50742-0521-10 | Ingenus Pharmaceuticals LLC | 10 | 400 |
J9073: common questions
- Is J9073 a CPT code?
- No. J9073 is a HCPCS Level II code, maintained by CMS, that identifies the drug supplied. CPT codes are five-digit numbers from the AMA that describe services. Giving the drug, for example an injection or infusion, is usually reported with a separate CPT administration code. CPT codes for drug administration.
- What NDCs are billed under J9073?
- CMS's ASP crosswalk for October 1, 2026 through December 31, 2026 lists 9 NDCs under J9073, for Cyclophosphamide and Cyclophosphamide (Ingenus). The table on this page shows each one with its billing units per package.
- What is the Medicare payment limit for J9073?
- $0.465 per 5 mg, effective October 1, 2026 through December 31, 2026, from CMS's Part B drug payment limit file. Multiply by the units billed for the allowed amount before deductible and coinsurance. It is not a coverage decision.
- What is one billing unit of J9073?
- One unit of J9073 is 5 mg, as stated in the code's descriptor. Units to report = dose given ÷ 5 mg. J-code billing units.